Kevin Esch
Known title: Executive Vice PresidentCIK: 0002099914
Associated companies
Transaction History
| ZTS | ▲ Buy | Option Exercise | 259 | — | 4/30/2026 | View on chart |
| ZTS | ▼ Sell | Tax Withholding | 75 | $9K | 4/30/2026 | View on chart |
| ZTS | ▲ Buy | Option Exercise | 102 | — | 2/19/2026 | View on chart |
| ZTS | ▼ Sell | Tax Withholding | 35 | $4K | 2/19/2026 | View on chart |
| ZTS | ▼ Sell | Tax Withholding | 18 | $2K | 2/8/2026 | View on chart |
| ZTS | ▲ Buy | Option Exercise | 50 | — | 2/8/2026 | View on chart |
| ZTS | ▲ Buy | Option Exercise | 43 | — | 2/6/2026 | View on chart |
| ZTS | ▼ Sell | Tax Withholding | 15 | $2K | 2/6/2026 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Goldman Sachs initiates Zoetis coverage with Neutral rating
Goldman Sachs began covering Zoetis with a Neutral rating and a $74 price target. This follows recent guidance cuts that the market initially shrugged off, alongside a new board appointment. The stock currently trades near a key support level, with an RSI of 71.0 indicating strong recent momentum.
Goldman Sachs initiates Zoetis coverage with Neutral rating. Goldman Sachs began covering Zoetis with a Neutral rating and a $74 price target. This follows recent guidance cuts that the market initially shrugged off, alongside a new board appointment. The stock currently trades near a key support level, with an RSI of 71.0 indicating strong recent momentum.